The company claims the device delivers an innovative, less painful alternative to the century-old tenaculum for intrauterine device (IUD) placement and other transcervical procedures. It is the first step toward a nationwide rollout says Aspivix.

Aspivix says that carevix is the world’s first clinically proven suction-based cervical stabiliser, designed to replace the century-old tenaculum, a sharp-toothed forceps still widely used in gynaecology. 

The company claims that studies demonstrate that the gentle suction technology reduces pain during IUD insertions by more than 70% and bleeding by over 80% compared to the use of a traditional tenaculum. Beyond IUDs, this new suction device is designed for a broad range of gynecological and fertility procedures, including hysteroscopies, embryo transfers, intrauterine inseminations (IUI), fallopian tube patency assessments, and endometrial biopsies.